Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.
22

Bausch + Lomb Launches Enhanced Pinnacle 360 Single-Use Instrument Line

New Features Offer Ease of Use, Efficiency

FOR RELEASE THURSDAY, SEPTEMBER 22, 2016

 

BRIDGEWATER, NJ – Bausch + Lomb, a leading global eye health company, today announced the launch of an enhanced version of its Pinnacle 360 line of single-use instruments.  

 

“The new Pinnacle 360 line is another example of our commitment to meeting and exceeding the needs of the retina community by continuing to innovate and deliver the best possible products,” said Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb. “The changes we’ve made to our Pinnacle 360 line provide ease of use and efficiency, and are the direct result of feedback we’ve received from our customers.”

 

The Pinnacle 360 instruments now feature a new piston, redesigned to provide smooth, consistent actuation. Bausch + Lomb also invested in new technology to design a strong, thinner internal limiting membrane (ILM) forceps that provides surgeons with excellent visualization, allowing them to see down to the tissue as they engage it. Additionally, all Pinnacle 360 instruments are now color-coded according to Bausch + Lomb’s standard gauge size identification, making it easier for surgical staff to select the appropriate instrument and thus improving efficiency.

 

“The new Pinnacle 360 ILM forceps provides exceptional grip strength and visualization,” said Drew Sommerville, M.D., President of Talley Eye Care and Medical Director of Valley Surgery Center in Evansville, IN. “I also appreciate the tip travel of the instrument, as it gives me great confidence in the grip I have on the membrane during the procedure.”

 

The enhanced Pinnacle 360 will be available for surgeons to test at the Bausch + Lomb booth (#3026) at the American Academy of Ophthalmology (AAO) in Chicago, October 15-18, 2016.

 

About Bausch + Lomb Retina
In September 2015, Bausch + Lomb acquired Synergetics®, bringing together agile innovation and enhanced resources, as well as the expertise of two organizations dedicated to serving the ophthalmology community with cutting-edge innovation of the highest quality. Our fully-integrated product portfolio now includes vitrectomy solutions such as the Stellaris® PC vision enhancement system and VersaVIT™, as well as instrumentation, laser probes and illumination, all developed with years of experience and the guidance of retinal surgeons worldwide. For more information, visit www.bauschretina.com.

About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight. Its core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries.

 

®/™ are trademarks of Bausch & Lomb Incorporated or its affiliates.

Any other product/brand names are trademarks of their respective owners.
© 2016 Bausch & Lomb Incorporated. SPC.0042.USA.16

 

# # #

News Media Contacts:
Kristy Marks
PR Product Manager, Bausch + Lomb
(908) 927-0683 or kristy.marks@bausch.com

Teresa Panas
BioComm Network, on behalf of Bausch + Lomb
(973) 809-8590 or tpanas@biocommnetwork.com

Actions: E-mail | Permalink |